Calmodulin-drug interaction. A fluorescence and flow dialysis study.

Various Ca2+-antagonists and related compounds were probed for possible anti-calmodulin properties. Some of them efficiently inhibit calmodulin dependent activity (the plasma membrane Ca2+-ATPase and the cyclic nucleotide phosphodiesterase). The I50-values for the most potent inhibitors varied between 15 and 30 uM. Using fluorescence spectroscopy and flow dialysis methods the stoichiometry of the binding of some of the drugs to calmodulin has been investigated. The number of Ca2+-dependent high affinity binding sites has been studied on trypsin fragments of calmodulin. Compound 12-114 was bound with high affinity in a Ca2+-dependent way to both halves of calmodulin, compound 200-737 recognized one high affinity binding site only in the C-terminal half of the molecule, whereas compound 36-079 demanded the intact protein to be able to interact with high affinity in a Ca2+-dependent manner.

[1]  B. Weiss,et al.  Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. , 1977, Molecular pharmacology.

[2]  A. Edelman,et al.  Characterization of the calmodulin-binding and catalytic domains in skeletal muscle myosin light chain kinase. , 1985, The Journal of biological chemistry.

[3]  J. Head,et al.  Identification and purification of a phenothiazine binding fragment from bovine brain calmodulin , 1982, FEBS letters.

[4]  H. Jarrett.  The synthesis and reaction of a specific affinity label for the hydrophobic drug-binding domains of calmodulin. , 1984, The Journal of biological chemistry.

[5]  A. Wüthrich,et al.  R 24571: a new powerful inhibitor of red blood cell Ca++-transport ATPase and of calmodulin-regulated functions. , 1981, Biochemical and biophysical research communications.

[6]  E. Carafoli,et al.  Stimulation of the purified erythrocyte Ca2+-ATPase by tryptic fragments of calmodulin. , 1984, The Journal of biological chemistry.

[7]  J. Krebs.  A survey of structural studies on calmodulin. , 1981, Cell calcium.

[8]  H. Vogel,et al.  Metal ion and drug binding to proteolytic fragments of calmodulin: proteolytic, cadmium-113, and proton nuclear magnetic resonance studies. , 1984, Biochemistry.

[9]  E. Carafoli,et al.  3-(Trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine, a hydrophobic, photoreactive probe, labels calmodulin and calmodulin fragments in a Ca2+-dependent way. , 1984, Biochemistry.

[10]  T. Vanaman,et al.  Azidotyrosylcalmodulin derivatives. Specific probes for protein-binding domains. , 1984, The Journal of biological chemistry.

[11]  M. Oehme,et al.  CALCIUM‐SELECTIVE ELECTRODES * , 1978 .

[12]  D. Malencik,et al.  Peptide binding by calmodulin and its proteolytic fragments and by troponin C. , 1984, Biochemistry.

[13]  D. Blumenthal,et al.  Effects of pH, ionic strength, and temperature on activation by calmodulin an catalytic activity of myosin light chain kinase. , 1982, Biochemistry.

[14]  D. Malencik,et al.  Binding of hormones and neuropeptides by calmodulin. , 1983, Biochemistry.

[15]  J. Johnson,et al.  A fluorescent calmodulin that reports the binding of hydrophobic inhibitory ligands. , 1983, The Biochemical journal.

[16]  V. Niggli,et al.  The anticalmodulin drugs trifluoperazine and R24571 remove the activation of the purified erythrocyte Ca2+‐ATPase by acidic phospholipids and by controlled proteolysis , 1982, FEBS letters.

[17]  E Carafoli,et al.  Influence of Ca2+ and trifluoperazine on the structure of calmodulin. A 1H-nuclear magnetic resonance study. , 2005, European journal of biochemistry.

[18]  H. Vogel,et al.  Cadmium-113 nuclear magnetic resonance studies of proteolytic fragments of calmodulin: assignment of strong and weak cation binding sites. , 1983, Biochemistry.

[19]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[20]  J. Kuźnicki,et al.  Characterization of tryptic fragments obtained from bovine brain protein modulator of cyclic nucleotide phosphodiesterase. , 1977, The Journal of biological chemistry.

[21]  A. Edelman,et al.  Identification of the calmodulin-binding domain of skeletal muscle myosin light chain kinase. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Weiss,et al.  Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships. , 1982, The Journal of pharmacology and experimental therapeutics.

[23]  P. A. Lanzetta,et al.  An improved assay for nanomole amounts of inorganic phosphate. , 1979, Analytical biochemistry.

[24]  J. Cox,et al.  Structural changes in melittin and calmodulin upon complex formation and their modulation by calcium. , 1983, Biochemistry.

[25]  S. Colowick,et al.  Binding of diffusible molecules by macromolecules: rapid measurement by rate of dialysis. , 1969, The Journal of biological chemistry.

[26]  Charles E. Bugg,et al.  Three-dimensional structure of calmodulin , 1985, Nature.

[27]  D. Newton,et al.  Calcium ion dependent covalent modification of calmodulin with norchlorpromazine isothiocyanate. , 1983, Biochemistry.

[28]  D. Guerini,et al.  Separation of various calmodulins, calmodulin tryptic fragments, and different homologous Ca2+-binding proteins by reversed-phase, hydrophobic interaction, and ion-exchange high-performance liquid chromatography techniques. , 1985, Analytical biochemistry.

[29]  D. Marshak,et al.  Drug-protein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins. , 1985, Biochemistry.

[30]  S. Forsén,et al.  Chapter 4 – Biophysical Studies of Calmodulin , 1986 .

[31]  J. T. Penniston,et al.  Purification of the (Ca2+-Mg2+)-ATPase from human erythrocyte membranes using a calmodulin affinity column. , 1979, The Journal of biological chemistry.

[32]  T. Bártfai.  Preparation of metal-chelate complexes and the design of steady-state kinetic experiments involving metal nucleotide complexes. , 1979, Advances in cyclic nucleotide research.

[33]  N. Ling,et al.  Demonstration by covalent cross-linking of a specific interaction between beta-endorphin and calmodulin. , 1983, The Journal of biological chemistry.

[34]  D. Storm,et al.  Calcium-induced exposure of a hydrophobic surface on calmodulin. , 1980, Biochemistry.

[35]  T. Tanaka,et al.  Hydrophobic regions function in calmodulin-enzyme(s) interactions. , 1980, The Journal of biological chemistry.

[36]  R. Kincaid,et al.  Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I. , 1982, The Journal of biological chemistry.

[37]  R. F. Chen.  Dansyl labeled proteins: determination of extinction coefficienc and number of bound residues with radioactive dansyl chloride. , 1968, Analytical biochemistry.

[38]  S. Forsén,et al.  A 113Cd NMR study of calmodulin and its interaction with calcium, magnesium and trifluoperazine , 1980, FEBS letters.

[39]  W. Drabikowski,et al.  Localization of hydrophobic sites in calmodulin and skeletal muscle troponin C studied using tryptic fragments: a simple method of their preparation. , 1983, Biochemical and biophysical research communications.

[40]  D. Marshak,et al.  Drug-protein interactions: isolation and characterization of covalent adducts of phenoxybenzamine and calmodulin. , 1985, Biochemistry.

[41]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[42]  H. Hidaka,et al.  Activity-structure relationship of calmodulin antagonists, Naphthalenesulfonamide derivatives. , 1981, Molecular pharmacology.

[43]  E. Sigel,et al.  A simple system for the measurement of ion activities with solvent polymeric membrane electrodes. , 1979, Analytical biochemistry.

[44]  D. Newton,et al.  Agonist and antagonist properties of calmodulin fragments. , 1984, The Journal of biological chemistry.